Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 998 of 6351
-
Could a less drastic surgery prevent ovarian cancer in High-Risk women?
Prevention Recruiting nowThis clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes,…
Sponsor: NRG Oncology • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
New chemo combo may offer hope for rare, aggressive gut cancer
Disease control Recruiting nowthere is a need for improving chemotherapy regimen for metastatic G3 NEC of GEP and Unknown origin and this goal may be achieved through more "personalized" chemotherapy regimen.the hypothesis is that mFOLFIRINOX regimen could be a good candidate for challenging the platinum-etop…
Phase 2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for kids with swallowing trouble: drug targets esophageal inflammation
Disease control CompletedThe Primary objective is to demonstrate the efficacy of dupilumab treatment compared with placebo in pediatric patients with active eosinophilic esophagitis (EoE) based on histologic improvement meeting validated histologic criteria. The Secondary objectives are: * To demonstra…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Immunotherapy duo takes on deadly brain tumor in major trial
Disease control CompletedThis phase II/III trial compares the usual treatment with radiation therapy and temozolomide to radiation therapy in combination with immunotherapy with ipilimumab and nivolumab in treating patients with newly diagnosed MGMT unmethylated glioblastoma. Radiation therapy uses high …
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Younger donors may improve stem cell transplant success for leukemia patients
Disease control OngoingAn open, multi-center, randomized trial comparing haploidentical HSCTs from young non-first-degree and older first-degree donors in hematological malignancies
Phase 3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Scientists hunt for hidden genetic causes of rare bleeding disorder
Knowledge-focused CompletedInherited thrombocytopenias (ITs) are rare conditions characterized by low platelet count resulting in impaired hemostasis. Recent advances revealed that several forms expose patients to the risk of developing additional and life-threatening disorders. Making a definite diagnosi…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New scan could replace risky vein test for Hormone-Driven high blood pressure
Diagnosis Recruiting nowPrimary aldosteronism is the most common cause of secondary hypertension. The two main types of primary aldosteronism are aldosteronoma(30%) and adrenal hyperplasia(60%). The gold standard that determines the diagnosis and treatment strategy of primary aldosteronism is adrenal ve…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
A smartphone intervention aims to improve teen sleep and mental health
Symptom relief CompletedThe present study will test an innovative mobile health adaptation of a behavioral intervention that improves sleep and mental health concerns among adolescents.
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Could a mediterranean diet ease picky eating in autism?
Symptom relief CompletedAutism Spectrum Disorder (ASD) is a complex group of behavioral disorders characterized by defects in social interaction and communication associated with restricted and repetitive behaviors and activities. The prevalence in pediatric age is continuously increasing in Western cou…
Sponsor: Federico II University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
A sharper eye for cancer: new PET tracer targets hidden tumors
Diagnosis Recruiting nowTo evaluate the potential usefulness of 68Ga/18F-PSMA/PSFA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various PSMA-related disease patients (prostate cancer, hepatic cancer, etc.).
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 09, 2026 15:00 UTC
-
20,000 seniors test if statins ward off dementia and disability
Prevention Recruiting nowPREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia wi…
Phase 4 • Sponsor: Duke University • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Triple threat: new malaria cocktail aims to outsmart resistance
Disease control CompletedA partially blinded randomised controlled non-inferiority trial comparing the efficacy, tolerability and safety of Triple ACTs artemether-lumefantrine+amodiaquine (AL+AQ) and artesunate-mefloquine+piperaquine (ASMQ+PPQ) and the ACTs artemether-lumefantrine+placebo (AL+PBO), artes…
Phase 3 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for kids with brain cancer? LAM561 trial launches
Disease control Recruiting nowAn open label, non-randomized study in pediatric patients with advanced high-grade gliomas and other solid tumors. The study will be performed in two phases: a dose escalation phase in up to 18 patients following a standard "3+3" design to establish dose-limiting toxicity (DLT) …
Phase 1/2 • Sponsor: Laminar Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New chemo cocktail shows promise for tough-to-treat colorectal cancer
Disease control OngoingThe current clinical trials and data on the triplet regimen combined with bevacizumab for first-line treatment of metastatic colorectal cancer were from European and American populations. The triplet regimens recommended by the NCCN and ESMO guidelines using irinotecan and 5-FU a…
Phase 3 • Sponsor: Yanhong Deng • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New study aims to bring depression and PTSD treatment to millions in kenya
Disease control CompletedDespite carrying the vast majority of the global mental disorder burden, 75% of adults with mental disorders in Low and Middle Income Countries have no access to services. This study will test strategies for integrating first and second line evidence-based depression and trauma-r…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a diabetes drug boost cancer immunotherapy?
Disease control OngoingThe purpose of this study is to determine anti-tumor activity by measuring overall response rate in recurrent and/or metastatic HNSCC patients receiving the combination of metformin and pembrolizumab.
Phase 2 • Sponsor: Trisha Wise-Draper • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for rare blood cancer: drug duo targets enlarged spleen
Disease control OngoingMyelofibrosis (MF) is a rare blood cancer, notable for scarring of the bone marrow (the spongy tissue inside bones) and the spleen becoming larger. The purpose of this study is to assess safety and change in spleen volume when navitoclax is given in combination with ruxolitinib, …
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Umbilical cord patch used in womb to repair spina bifida
Disease control OngoingTo fetoscopically use cryopreserved human umbilical cord allografts, named NEOX Cord 1K®, as a spinal cord cover of spina bifida defects. This procedure will be performed to create a watertight seal covering over the spinal cord in order to decrease the incidence rates of postnat…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can smart sensors predict falls before they happen?
Diagnosis CompletedIn patients with chronic illness, screening for falls and their health consequences are major public health issues. Muscle weakness, gait and balance disorders are among the most common risk factors for falling. Assessing these parameters would thus be a crucial step in the evalu…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 07, 2026 00:00 UTC
-
Simple blood test could revolutionize Alzheimer's diagnosis
Diagnosis Recruiting nowThe study will investigate the biomarkers of Aβ and Tau seeds in plasma detected by Alzheimer's disease (AD) related seeds quantitative detector (AD-seeds-detector), and their sensitivity and specificity in diagnosing AD, compared with those from age-matched cognitively normal co…
Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC